Cargando…

The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates

The aim of this study was to investigate the relationship between nonalcoholic fatty liver disease (NAFLD) and pancreatic steatosis (PS) in patients with biopsy-proven NAFLD. 228 patients with biopsy-proven NAFLD patients who admitted to the Faculty of Medicine of Demiroglu Bilim University between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koyuncu Sokmen, Bedriye, Sahin, Tolga, Oral, Alihan, Kocak, Erdem, Inan, Nagihan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904852/ https://www.ncbi.nlm.nih.gov/pubmed/33627704 http://dx.doi.org/10.1038/s41598-021-83871-0

Ejemplares similares

Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
por: Oral, Alihan, et al.
Publicado: (2019)

Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study
por: Oral, Alihan, et al.
Publicado: (2019)

Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis?
por: Sahin, Tolga, et al.
Publicado: (2020)

Factor 5 and Factor 2 heterozygous positivity and complications in living donor liver transplant donors
por: Anilir, Ender, et al.
Publicado: (2023)

Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
por: Türker, Fatih, et al.
Publicado: (2021)

Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis
por: Türker, Fatih, et al.
Publicado: (2022)

Prognostic role of ABO blood group and Rhesus factor in cirrhotic patients with hepatocellular carcinoma
por: Oral, Alihan, et al.
Publicado: (2019)

Incidental combined hepatocellular-cholangiocarcinoma in liver transplant patients: Does it have a worse prognosis?
por: Anilir, Ender, et al.
Publicado: (2023)

Efficacy and Safety of Weight Reduction of the Donor in Hepatic Steatosis for Living Donor Liver Transplantation
por: Chung, Jae Hun, et al.
Publicado: (2020)

Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods
por: Kim, Jong Man, et al.
Publicado: (2016)

Identification of hepatic steatosis in living liver donors by machine learning models
por: Lim, Jihye, et al.
Publicado: (2022)

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
por: Broering, Dieter, et al.
Publicado: (2021)

HOW USEFUL IS ELASTOGRAPHY IN THE FOLLOW-UP OF ACHILLES TENDON REPAIR?
por: Çetin, Mehmet ümit, et al.
Publicado: (2022)

Banff consensus recommendations for steatosis assessment in donor livers
por: Neil, Desley A. H., et al.
Publicado: (2021)

Clinical Outcome of Residual Liver Volume and Hepatic Steatosis After Right-Lobe Living-Donor Hepatectomy
por: Hsieh, Chia-En, et al.
Publicado: (2020)

Hepatic artery reconstruction with gonodal vein interposition: First case in patients receiving liver from the living donor
por: Dinckan, Ayhan, et al.
Publicado: (2012)

Preoperative evaluation of liver volume in living donor liver transplantation
por: Baskiran, Adil, et al.
Publicado: (2017)

Xanthoma striatum palmare
por: Oral, Alihan, et al.
Publicado: (2016)

Tacrolimus-induced gingival hyperplasia and recovery from tacrolimus to everolimus switching
por: Oral, Alihan, et al.
Publicado: (2019)

Assessment of Liver Regeneration in Patients Who Have Undergone Living Donor Hepatectomy for Living Donor Liver Transplantation
por: Satilmis, Basri, et al.
Publicado: (2023)

Non-invasive real-time assessment of hepatic macrovesicular steatosis in liver donors: Hypothesis, design and proof-of-concept study
por: Rajamani, Allwyn S, et al.
Publicado: (2021)

Lose Weight to Donate: Development of a Program to Optimize Potential Donors With Hepatic Steatosis or Obesity for Living Liver Donation
por: Rose, John T., et al.
Publicado: (2021)

Deep learning quantification of percent steatosis in donor liver biopsy frozen sections
por: Sun, Lulu, et al.
Publicado: (2020)

A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction
por: Satapathy, Sanjaya K., et al.
Publicado: (2020)

Comment on pediatric living donor liver transplantation decade progress in Shanghai: Characteristics and risks factors of mortality
por: Akbulut, Sami, et al.
Publicado: (2020)

S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis
por: Tsuji, Kunihiro, et al.
Publicado: (2017)

Pembrolizumab-Induced Pancreatic Exocrine Insufficiency Complicated by Severe Hepatic Steatosis
por: Hong, Alex S, et al.
Publicado: (2022)

Donor liver steatosis: A risk factor for early new‐onset diabetes after liver transplantation
por: Xue, Mengjuan, et al.
Publicado: (2016)

A Clinical Tool to Guide Selection and Utilization of Marginal Donor Livers With Graft Steatosis in Liver Transplantation
por: Steggerda, Justin A., et al.
Publicado: (2022)

Changes in Indices of Steatosis and Fibrosis in Liver Grafts of Living Donors After Weight Reduction
por: Choi, Jaehyuk, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Comparison of hepatic steatosis index as noninvasive diagnostic tool and liver ultrasound for non-alcoholic steatosis in the adult population
por: Khani, Vahid, et al.
Publicado: (2022)

Electromagnetic Interference Shielding Performances of Carbon-Fiber-Reinforced PA11/PLA Composites in the X-Band Frequency Range
por: Ucpinar Durmaz, Bedriye, et al.
Publicado: (2023)

Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients
por: Ferri, Flaminia, et al.
Publicado: (2019)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
por: Wells, Malcolm M., et al.
Publicado: (2016)

Palmitoleate Induces Hepatic Steatosis but Suppresses Liver Inflammatory Response in Mice
por: Guo, Xin, et al.
Publicado: (2012)

Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance
por: Kahl, Sabine, et al.
Publicado: (2014)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tcb45s4hljbl7o64vjo5ouuqqf